CA
AGN

Clearstead Advisors’s Allergan plc AGN Stock Holding History

Clearstead Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,347
Closed -$416K – 853
2020
Q1 		$416K Sell
2,347
-886
-27% -$167K 0.06% 170
2019
Q4 		$618K Buy
3,233
+601
+23% +$108K 0.08% 158
2019
Q3 		$443K Buy
+2,632
New +$429K 0.06% 178

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Clearstead Advisors's AGN Position: Q2 2020 in Review

Clearstead Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,347 shares — an estimated $416K sold.

Clearstead Advisors first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $618K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Clearstead Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Clearstead Advisors sold 2,347 Allergan plc shares in Q2 2020, an estimated $416K.
  • Clearstead Advisors first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Clearstead Advisors's Allergan plc position peaked at $618K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Clearstead Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.